---
layout: post
title: PDE3B
date: 2025-01-17 16:55 CST
description: PDE3B description
tags: [cooccuring-genes]
categories: unknown-mechanism
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/5140) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 5140  | PDE3B | ENSG00000152270 | 11p15.2 |



The gene is involved in various biological processes, including [angiogenesis](https://amigo.geneontology.org/amigo/term/GO:0001525), [negative regulation of cell adhesion](https://amigo.geneontology.org/amigo/term/GO:0007162), [G protein-coupled receptor signaling pathway](https://amigo.geneontology.org/amigo/term/GO:0007186), [negative regulation of angiogenesis](https://amigo.geneontology.org/amigo/term/GO:0016525), [cAMP-mediated signaling](https://amigo.geneontology.org/amigo/term/GO:0019933), [cellular response to insulin stimulus](https://amigo.geneontology.org/amigo/term/GO:0032869), [negative regulation of cell adhesion mediated by integrin](https://amigo.geneontology.org/amigo/term/GO:0033629), [negative regulation of cAMP-mediated signaling](https://amigo.geneontology.org/amigo/term/GO:0043951), and [negative regulation of lipid catabolic process](https://amigo.geneontology.org/amigo/term/GO:0050995). It enables several molecular functions, such as [3',5'-cyclic-nucleotide phosphodiesterase activity](https://amigo.geneontology.org/amigo/term/GO:0004114), [3',5'-cyclic-AMP phosphodiesterase activity](https://amigo.geneontology.org/amigo/term/GO:0004115), [cGMP-inhibited cyclic-nucleotide phosphodiesterase activity](https://amigo.geneontology.org/amigo/term/GO:0004119), [protein binding](https://amigo.geneontology.org/amigo/term/GO:0005515), [protein kinase B binding](https://amigo.geneontology.org/amigo/term/GO:0043422), [metal ion binding](https://amigo.geneontology.org/amigo/term/GO:0046872), and [3',5'-cyclic-GMP phosphodiesterase activity](https://amigo.geneontology.org/amigo/term/GO:0047555). The gene is located in the [endoplasmic reticulum](https://amigo.geneontology.org/amigo/term/GO:0005783), [Golgi apparatus](https://amigo.geneontology.org/amigo/term/GO:0005794), [cytosol](https://amigo.geneontology.org/amigo/term/GO:0005829), and [membrane](https://amigo.geneontology.org/amigo/term/GO:0016020), and is part of the [guanyl-nucleotide exchange factor complex](https://amigo.geneontology.org/amigo/term/GO:0032045).


The gene length is 55,960 base pairs (69.36% of all genes), the mature length is 7,573 base pairs (97.2% of all genes), and the primary transcript length is 30,743.5 base pairs (63.24% of all genes).


The gene PDE3B, with NCBI ID 5140, has been mentioned in [245 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22PDE3B%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727). The earliest year of publication is 1966, and the middle 50% of publications occurred between 1978 and 1997.


The top 5 publications mentioning PDE3B, ranked by their scientific influence, include [Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.](https://pubmed.ncbi.nlm.nih.gov/2159198) (1990) (relative citation ratio: 25.57), [Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.](https://pubmed.ncbi.nlm.nih.gov/18661) (1977) (relative citation ratio: 20.5), [Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.](https://pubmed.ncbi.nlm.nih.gov/34709) (1979) (relative citation ratio: 18.52), [Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.](https://pubmed.ncbi.nlm.nih.gov/16102838) (2006) (relative citation ratio: 16.21), and [Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.](https://pubmed.ncbi.nlm.nih.gov/9598563) (1998) (relative citation ratio: 13.74). The [Relative Citation Ratio (RCR)](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002541) measures the scientific influence of each paper by field- and time-adjusting the citations it has received, benchmarking to the median for NIH publications, which is set at 1.0. Citation counts are sourced from [iCite](https://icite.od.nih.gov).


[PDE3B](https://www.proteinatlas.org/ENSG00000152270-PDE3B) is a hydrolase with evidence at the protein level, making it an FDA-approved drug target. It is detected in many tissues and is primarily located in the endoplasmic reticulum. The gene is expressed in various clusters, including Cluster 43 for blood (non-specific - transcription & translation), Cluster 11 for tissue (liver - plasma proteins), Cluster 35 for brain (non-specific - DNA binding), Cluster 59 for cell lines (leukemia - T-cell receptor), and Cluster 78 for single cells (NK-cells & T-cells - immune system & transcription).


The top transcription factors (TFs) identified from GTRD's database of TF binding sites, based on the number of CHIP-seq experiments, include [TP53BP1](https://www.ncbi.nlm.nih.gov/gene/7158), [BRD9](https://www.ncbi.nlm.nih.gov/gene/65980), [TRPS1](https://www.ncbi.nlm.nih.gov/gene/7227), and [GATA2](https://www.ncbi.nlm.nih.gov/gene/2624), each with 5 experiments. Additionally, [MAX](https://www.ncbi.nlm.nih.gov/gene/4149) was found to be regulating in 4 experiments.



The GWAS data indicates associations with a range of disease conditions, including iris disease, uveal disease, various metabolic disorders such as diabetes mellitus (particularly type 2 diabetes mellitus), obesity, and cardiovascular system disease. Additionally, the data highlights links to kidney disease, urinary system disease, nervous system disease, and eye-related conditions, including sensory system disease and metabolic syndrome X.


PDE3B has been associated with various traits and diseases through genome-wide association studies. Notably, it has been linked to [Adiponectin levels](https://pubmed.ncbi.nlm.nih.gov/31178129), which maps to the MeSH term [Adiponectin](https://meshb.nlm.nih.gov/record/ui?ui=D052242) using the BioWordVec method. Additionally, PDE3B is associated with [Apolipoprotein A1 levels](https://pubmed.ncbi.nlm.nih.gov/33462484) and [Apolipoprotein B levels](https://pubmed.ncbi.nlm.nih.gov/33462484), both mapping to the MeSH term [Apolipoproteins](https://meshb.nlm.nih.gov/record/ui?ui=D001053). Other associations include [HDL cholesterol](https://pubmed.ncbi.nlm.nih.gov/30275531), mapping to [Cholesterol, HDL](https://meshb.nlm.nih.gov/record/ui?ui=D008076), and [HDL cholesterol levels](https://pubmed.ncbi.nlm.nih.gov/34226706), mapping to [Cholesterol](https://meshb.nlm.nih.gov/record/ui?ui=D002784). Furthermore, PDE3B is linked to [High density lipoprotein cholesterol levels](https://pubmed.ncbi.nlm.nih.gov/33462484), mapping to [Lipoproteins](https://meshb.nlm.nih.gov/record/ui?ui=D008074), and [High light scatter reticulocyte count](https://pubmed.ncbi.nlm.nih.gov/32888494), mapping to [Reticulocytes](https://meshb.nlm.nih.gov/record/ui?ui=D012156). Other notable associations include [Mean sphered cell volume](https://pubmed.ncbi.nlm.nih.gov/34226706), mapping to [Cells](https://meshb.nlm.nih.gov/record/ui?ui=D002477), [Non-HDL cholesterol levels](https://pubmed.ncbi.nlm.nih.gov/34887591), mapping to [Cholesterol](https://meshb.nlm.nih.gov/record/ui?ui=D002784), and [Reticulocyte count](https://pubmed.ncbi.nlm.nih.gov/32888494), mapping to [Reticulocyte Count](https://meshb.nlm.nih.gov/record/ui?ui=D017701). Additionally, PDE3B is associated with [Reticulocyte fraction of red cells](https://pubmed.ncbi.nlm.nih.gov/32888494), mapping to [Reticulocytes](https://meshb.nlm.nih.gov/record/ui?ui=D012156), [Sex hormone-binding globulin levels](https://pubmed.ncbi.nlm.nih.gov/34226706), mapping to [Globulins](https://meshb.nlm.nih.gov/record/ui?ui=D005916), and [Triglyceride levels](https://pubmed.ncbi.nlm.nih.gov/33462484), mapping to [Triglycerides](https://meshb.nlm.nih.gov/record/ui?ui=D014280). Lastly, PDE3B is linked to [Triglycerides](https://pubmed.ncbi.nlm.nih.gov/30275531), mapping to [Triglycerides](https://meshb.nlm.nih.gov/record/ui?ui=D014280), and [Waist-to-hip ratio adjusted for BMI](https://pubmed.ncbi.nlm.nih.gov/30239722), mapping to [Adaptation, Psychological](https://meshb.nlm.nih.gov/record/ui?ui=D000223).


The gene is expressed in adipose tissue and colon according to the BioGPS Human Cell Type and Tissue Gene Expression Profiles. Additionally, the GTEx Tissue Gene Expression Profiles indicate expression in CD4+ T cells, CD8+ T cells, adipocytes, salivary gland, appendix, superior cervical ganglion, and testis Leydig cells.


The input data highlights various signaling pathways and biological processes, including inhibition of HSL, PDE3B signaling, and multiple pathways related to IGF1R and insulin receptor signaling. Additionally, it covers GPCR downstream signaling, PI3K cascade, and signal transduction. The data also includes nitric oxide stimulation of guanylate cyclase, cGMP effects, and processes related to platelet homeostasis and hemostasis. Furthermore, PKB-mediated events are mentioned.


The mouse ortholog gene 18576 is associated with the phenotype 'long tibia', and its human ortholog is gene 5140. This phenotype is not observed in both sexes.


The analyzed protein sequence has a GRAVY value of -0.388 (47.56th percentile), indicating a hydrophilic nature. The charge at pH 7.0 is -25.97 (7.6th percentile), and the median structural flexibility is 1.002 (52.27th percentile). The protein has a high instability index of 61.32 (85.34th percentile) and an isoelectric point of 5.61 (20.75th percentile). The sequence length is 1112 amino acids (90.08th percentile) with a molecular weight of 124332.04 Da (90.19th percentile). The secondary structure affinities are 31.03% for helix (41.26th percentile), 32.37% for sheet (41.75th percentile), and 33.18% for turn (82.79th percentile). For more details on the sequence analysis, refer to the [BioPython ProtParam documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).





| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | yes    |